Paper9593151
Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods.
Klepser ME and 4 others. Antimicrob Agents Chemother, 1998. Cited by 257 papers, by iCite.
Cite this record
ConductScience Library. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Papers, record 9593151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9593151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| Candida | Major topic |
| Microbial Sensitivity Tests | Major topic |
| Colony Count, Microbial | |
| Drug Evaluation | |
| Research Design |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7447427 | Method of reliable determination of minimal lethal antibiotic concentrations. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7447427 | PubMed |
| 2 | 9078447 | Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp. | Diagn Microbiol Infect Dis | 1996 | https://conductscience.org/library/papers/9078447 | PubMed |
| 3 | 9087485 | In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9087485 | PubMed |
| 4 | 9578168 | Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans. | J Antimicrob Chemother | 1998 | https://conductscience.org/library/papers/9578168 | PubMed |
| 5 | 9174207 | Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9174207 | PubMed |
| 6 | 9458979 | Growth medium effect on the antifungal activity of LY 303366. | Diagn Microbiol Infect Dis | 1997 | https://conductscience.org/library/papers/9458979 | PubMed |
| 7 | 9114154 | Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. | Clin Infect Dis | 1997 | https://conductscience.org/library/papers/9114154 | PubMed |
Cited by128
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 257 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931223 | Effects of Sanghuang Extract on Candida albicans Colonization and Intestinal Inflammation in a DSS-Induced Colitis Mouse Model. | Pathogens | 2026 | https://conductscience.org/library/papers/42931223 | PubMed |
| 42540316 | An Organoselenium Compound Induces Death in Cryptococcus gattii Yeast by Apoptosis and Necrosis and Shows Antifungal Efficacy in Galleria mellonella. | ACS Omega | 2026 | https://conductscience.org/library/papers/42540316 | PubMed |
| 42518468 | Novel Inhibitors Targeting Urease Promote Fungicidal and Antivirulence Effects in Cryptococcus. | ACS Omega | 2026 | https://conductscience.org/library/papers/42518468 | PubMed |
| 42346571 | In Vitro Evaluation of Olorofim and Amphotericin B Combination Therapy Against Talaromyces marneffei. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42346571 | PubMed |
| 42289527 | Microbial biotransformation of Syzygium australe modifies metabolomic profile assessed with multivariate analysis and molecular networking: In vitro and computational studies. | Sci Rep | 2026 | https://conductscience.org/library/papers/42289527 | PubMed |
| 42223519 | Rapid exploration of anti-MRSA components from plants of Salvia. | Nat Prod Bioprospect | 2026 | https://conductscience.org/library/papers/42223519 | PubMed |
| 42198433 | Candicidal Effect of a Nanoemulsion Based on the Essential Oil of the Medicinal Plant Haplopappus foliosus: Role of Main Compounds in Yeast Inhibition. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198433 | PubMed |
| 42047263 | Synergistic antibacterial activity and mechanism of arginine combined with florfenicol against Escherichia coli. | Virulence | 2026 | https://conductscience.org/library/papers/42047263 | PubMed |
| 41704551 | Anti-Shigella activity and killing kinetics of compounds from MMV Pathogen and COVID Boxes: Identifying leads against Shigellosis. | Curr Res Pharmacol Drug Discov | 2026 | https://conductscience.org/library/papers/41704551 | PubMed |
| 41476504 | Targeting Non-albicans Candida Strains and Phytopathogenic Fusarium Species with Chitooligosaccharides: Insights into the Antifungal Mechanism. | ACS Omega | 2025 | https://conductscience.org/library/papers/41476504 | PubMed |
| 41474803 | In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosis. | PLoS Negl Trop Dis | 2025 | https://conductscience.org/library/papers/41474803 | PubMed |
| 41040159 | In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for Talaromycosis. | bioRxiv | 2025 | https://conductscience.org/library/papers/41040159 | PubMed |
| 40952940 | Biocompatible Guanidine-Functionalized Compounds with Biofilm and Membrane Disruptive Activity Against MRSA. | ACS Infect Dis | 2025 | https://conductscience.org/library/papers/40952940 | PubMed |
| 40893255 | Bixin from Bixa orellana L.: Analytical Method Validation, Physicochemical Characterization, and Selective Antifungal Activity against Candida spp. . | ACS Omega | 2025 | https://conductscience.org/library/papers/40893255 | PubMed |
| 40872309 | Chemical Composition, Biocompatibility, and Anti-Candida albicans Activity of Schinus weinmanniifolia Mart. ex Engl. | Pathogens | 2025 | https://conductscience.org/library/papers/40872309 | PubMed |
| 40871505 | Synergistic Antibacterial Effect of Eugenol and Biogenic Silver Nanoparticles on Staphylococcus pseudintermedius Isolated from Canine Keratoconjunctivitis Sicca. | Molecules | 2025 | https://conductscience.org/library/papers/40871505 | PubMed |
| 40219128 | Synergistic Antibacterial Interaction of Geraniol and Biogenic Silver Nanoparticles on Methicillin-Resistant Staphylococcus aureus. | Plants (Basel) | 2025 | https://conductscience.org/library/papers/40219128 | PubMed |
| 39863777 | Therapeutic alternatives for sporotrichosis induced by wild-type and non-wild-type Sporothrix schenckii through in vitro and in vivo assessment of enilconazole, isavuconazole, posaconazole, and terbinafine. | Sci Rep | 2025 | https://conductscience.org/library/papers/39863777 | PubMed |
| 39673050 | Chemical profile, antioxidant, antifungal, and cytotoxic activities of propolis from the stingless bee Tetragona clavipes. | Braz J Microbiol | 2025 | https://conductscience.org/library/papers/39673050 | PubMed |
| 39617796 | Synthesis, characterization, quantum chemical modelling, molecular docking, in silico and in vitro assessment of 3-(2-bromo-5-fluorophenyl))-1-(thiophen-2-yl)prop-2-en-1-one. | Sci Rep | 2024 | https://conductscience.org/library/papers/39617796 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9593151
GET https://conductscience.org/api/papers/v1/9593151/cited_by?page=2